ATE298239T1 - Immunomodulierende zusammensetzungen enthaltend harnstoff derivate zur behandlung von entzündungskrankheiten - Google Patents

Immunomodulierende zusammensetzungen enthaltend harnstoff derivate zur behandlung von entzündungskrankheiten

Info

Publication number
ATE298239T1
ATE298239T1 AT00920167T AT00920167T ATE298239T1 AT E298239 T1 ATE298239 T1 AT E298239T1 AT 00920167 T AT00920167 T AT 00920167T AT 00920167 T AT00920167 T AT 00920167T AT E298239 T1 ATE298239 T1 AT E298239T1
Authority
AT
Austria
Prior art keywords
treatment
compositions containing
inflammatory diseases
urea derivatives
containing urea
Prior art date
Application number
AT00920167T
Other languages
English (en)
Inventor
Andrew B Onderdonk
Arthur O Tzianabos
Robert J Miller
Pericles Calias
Original Assignee
Genzyme Corp
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp, Brigham & Womens Hospital filed Critical Genzyme Corp
Priority claimed from PCT/US2000/009087 external-priority patent/WO2000059490A2/en
Application granted granted Critical
Publication of ATE298239T1 publication Critical patent/ATE298239T1/de

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT00920167T 1999-04-06 2000-04-06 Immunomodulierende zusammensetzungen enthaltend harnstoff derivate zur behandlung von entzündungskrankheiten ATE298239T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12817799P 1999-04-06 1999-04-06
US18842200P 2000-03-10 2000-03-10
PCT/US2000/009087 WO2000059490A2 (en) 1999-04-06 2000-04-06 Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions

Publications (1)

Publication Number Publication Date
ATE298239T1 true ATE298239T1 (de) 2005-07-15

Family

ID=26826354

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00920167T ATE298239T1 (de) 1999-04-06 2000-04-06 Immunomodulierende zusammensetzungen enthaltend harnstoff derivate zur behandlung von entzündungskrankheiten

Country Status (4)

Country Link
EP (1) EP1171136B1 (de)
JP (1) JP2002541099A (de)
AT (1) ATE298239T1 (de)
DE (1) DE60020951T2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8658148B2 (en) 2007-06-22 2014-02-25 Genzyme Corporation Chemically modified dendrimers
CN112584878A (zh) * 2018-08-30 2021-03-30 樱花精机株式会社 腱和腱鞘的再生、修复材料及修复材料的应用
WO2021217041A1 (en) * 2020-04-24 2021-10-28 Immvention Therapeutix N-substituted alpha-amino and alpha-hydroxy carboxamide derivatives

Also Published As

Publication number Publication date
EP1171136A2 (de) 2002-01-16
JP2002541099A (ja) 2002-12-03
EP1171136B1 (de) 2005-06-22
DE60020951T2 (de) 2006-05-24
DE60020951D1 (de) 2005-07-28

Similar Documents

Publication Publication Date Title
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60108754D1 (de) Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60028358D1 (de) Hmg1 antagonisten zur behandlung von entzündungen
DE60031710D1 (de) Fettsäurederivat zur behandlung von externen sekretionsstörungen
DE69734513D1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE455106T1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
EP1017402A4 (de) Behandlung des übersäuerten darmsyndroms
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
ATE350364T1 (de) Adamantanderivate zur behandlung von entzündlichen, immunologischen und kardiovaskulären erkrankungen
ATE269303T1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE60023872D1 (de) Verfahren zur erhöhung der biologischen effektivität von zusammensetzungen zur pflanzenbehandlung
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60030554D1 (de) Verwendungen von et743 zur behandlung von krebs
EE200100397A (et) Kompositsioonid inflammatoorse reaktsiooni käitluseks
EP1117431A4 (de) Behandlung von acidose
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
ATE430577T1 (de) Ppar delta-inhibitoren zur behandlung kardiovasculärer erkrankungen
DE60120990D1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE60020951D1 (de) Immunomodulierende zusammensetzungen enthaltend harnstoff derivate zur behandlung von entzündungskrankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties